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Scutellaria baicalensis which is a traditional plant amedica in China possesses a wide anti-cancer 
effect. However, the inhibition effect and mechanism of S. baicalensis on cervical cancer is not clear up 
to now. In our study, two kinds of ethanol extract of S. baicalensis were used in U14 cervical cancer 
mice. The rate of tumor inhibition was detected, and the tumor cell morphology was observed by 
hematoxylin and eosin (H.E.) staining method. The cell cycle and apoptosis rate were examined by flow 
cytometry and the content of tumor necrosis factor-alpha (TNF-α) in serum was determined by enzyme-
linked immunosorbent assay (ELISA) kit. Furthermore, the expression of B-cell lymphoma 2 (Bcl-2) and 
Bax gene was detected by immunohistochemistry method. The results showed that the tumor growth 
could be inhibited with the highest inhibition rate of 59.86% and the apoptosis of tumor cells could be 
induced and cell cycles were arrested at S phase in the ethanol extract of S. baicalensis groups. 
Besides, the content of TNF-α in serum was significantly increased (P<0.05). The Bcl-2 positive cells got 
significance reduction and Bax positive cells were increased. So we conclude that the ethanol extract of 
S. baicalensis can inhibit the growth of tumor cells, arrest the cell cycle and induce the cells apoptosis 
and increase the content of tumor necrosis factor-alpha TNF-α in serum. The mechanism of anti-tumor 
activity might be associated with down regulating the level of Bcl-2 gene and up regulating the level of 
Bax gene. 
 





Cervical cancer is one of the most common woman 
cancers in the world, there were about 500,000 new 
cases of cervical cancer reported worldwide annually and 
cervical cancer has become the main reason of women 
death in the developing countries. People discover that 
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not only markedly lessen the clinical symptoms, but also 
lessen  the  toxicity  and  enhance  the  therapeutic  effect 
when coordinating with radiotherapy and chemotherapy. 
Studies have shown that some plant amedica ingredients 
can inhibit the proliferation of cervical cancer cells and 
promote the apoptosis of cancer cells. The dry root of 
Scutellaria baicalensis Georgi has been one of the most 
popular plant amedica in China for a long time. It can be 
used as an ingredient in clinical formulation; moreover, it 
is usually used as the raw material in traditional Chinese 





baicalensis Georgi is a multi-purpose plant amedica, and 
its main bioactive ingredients can inhibit the proliferation 
of many cancer cell lines (Min, 2009). The combination of 
baicalein and baicalin, which were  the  main  flavones  of 
S. baicalensis Georgi, could induce apoptosis of human 
breast cancer MCF-7 cells, and activate caspase-3 and -
9, meanwhile, down-regulate the expression of Bcl-2 
gene and up-regulate the expression of Bax gene and 
p53 (Zhou et al., 2009). Wogonin could inhibit the 
proliferation of ovarian A2780 cells and induce the cell 
apoptosis, and the anti-cancer mechanism might be 
related with inducing apoptosis (Li et al., 2003). Gao et al. 
(2011) observed that the absolute ethanol extract of S. 
baicalensis could induce the apoptosis of lung cancer 
cells and meanwhile increase the expression of p53 gene 
and Bax (Gao et al., 2011).  
So far little about the anti-cancer effects of S. 
baicalensis Georgi on cervical cancer has been reported, 
in order to discover the anti-cancer mechanism of ethanol 
extract of S. baicalensis Georgi and find a new herb 
component to treat cervical cancer, the ethanol extract 
(30% ethanol extract) of S. baicalensis Georgi (ESBI) and 
the ethanol extract II (50% ethanol extract) of S. 
baicalensis Georgi (ESBII) were isolated and treated on 
the cervical cancer U14 mice tumor model. The effects of 
ESBI and II on anti-tumor, cell apoptosis and cell cycle, 
and tumor necrosis factor-alpha (TNF-α) were 
determined, respectively, moreover, the expression of 
anti-apoptotic protein Bcl-2 and pro-apoptotic protein Bax 
was also detected in our study. 
 
 
MATERIALS AND METHODS 
 
Instruments and chemicals 
 
The powder of S. baicalensis Georgi was bought from MinLe 
Pharmacy of Qinhuangdao in Hebei province of China (which grows 
in Inner Mongolia Autonomous Region in China). Cyclo-
phosphamide (CTX) was purchased from Shanxi Powerdone 
Pharmaceutics Company Limited of China, and prepared for the 
concentration of 25 mg/kg by physiological saline. Hematoxylin and 
eosin (H.E.) staining kit and cell cycle and apoptosis analysis kit 
were obtained from Beyotime Institute of Biotechnology of China. 
Mouse TNF-α enzyme-linked immunosorbent assay (ELISA) kit was 
purchased from Becton, Dickinson and Company of America. 
Immunohistochemical staining kit and concentrated diamino-
benzidine (DAB) kit were bought from Zhongshan Goldenbridge 
Biotechnology Company Limited of China. Rabbit anti-Bcl-2 and 
rabbit anti-Bax were purchased from Beijing biosynthesis 
biotechnology Company Limited of China. All other chemicals used 





Female Kun Ming mice of six weeks old (21 to 23 g) were provided 
by the Experimental Animal Center of Chinese Military Academy of 
Medical Sciences, the Lot Number was SCXK-(Army) 2007-004. 
The mice were kept in plastic cages in a clean room with the 
appropriate temperature (20±1°C) and humidity, and provided 8 to 
10 h illumination every day. They were  fed  with  a  standard  pellet  




diet and water ad libitum. The animals were treated according to the 
National Institute of Health Guide for the care and use of laboratory 
animals and their experimental use were approved by the animal 





Mouse cervical cancer U14 cell line was obtained from the Peking 
Cancer Hospital Cell Bank of Chinese Academy Medical Sciences 
and adjusted to 5×10
6
 cells/ml by saline. 
 
 
Preparation of ethanol extract of S. baicalensis Georgi 
 
The powder of S. baicalensis Georgi was exhaustively extracted 
with 90% ethanol of five time volumes (g/ml) and got heat 
circumfluence for 2 h twice at 80°C. The concentrated liquid was 
collected after removing the solvent by evaporation under reduced 
pressure, and then got through the silica gel column 
chromatography. The collected liquid (50 ml) was ESBI while the 
eluent were 30% ethanol and then the collected liquid (50 ml) was 
ESBII while the eluent were 50% ethanol. ESBI and II liquid were 
put in drying oven to cryodry. 
 
 
Establishment of cervical cancer model in mice 
 
The mice were fed with water but without food for 12 h before the 
model establishment. Under the sterile condition, 0.2 ml U14 cells 
(5×10
6 
cells/ml) were injected into the left axilla s.c. per mouse. The 
rate of successful vaccination was 100%. After 24 h of vaccination, 
the mice were randomly divided into eight groups, and each group 
got 10 animals. The mice of the ESBI treated groups (1000, 500 
and 250 mg/kg) and the ESBII treated groups (1000, 500 and 250 
mg/kg) were given orally of 0.2 ml extract liquid every day. The 
group administered with 0.2 ml distilled water every day was taken 
as control and the group treated with cyclophosphamide (CTX, 25 
mg/kg/day, i.p.) was considered as the standard reference drug. All 
groups were continuously treated for 14 days. The living conditions 
of mice were observed every day, meanwhile, the changes of tumor 
volume and body weight were monitored. 
 
 
Effect of ESBI and II on solid tumor growth 
 
On day 15, all of the mice were killed, and then transplanted tumors 
of mice were harvested and weighted. The rate of tumor inhibition 
was calculated by the formula: (C-T)/C×100%, where “T” and “C” 
meant average tumor weight of treated groups and control group. 
 
 
Effect of ESBI and II on tumor cell morphology 
 
The tumor of mice in all groups were excised, and fixed in 10% 
neutral formalin at 4°C, embedded in paraffin, cut into 4 μm 
sections for histology study. The sections were stained with H.E. 
staining method and histological examinations were carried out 
under light microscopy. 
 
 
Effect of ESBI and II on cell cycle and cells apoptosis of tumor 
tissues 
 
The tumor tissues (about 1 to 2 mm
3
) of all groups were cut into 
pieces, and made into single cell suspension by filtered through 200 
mesh nylon net. The cell concentration was adjusted to 1×10
6
 
cells/ml after being centrifugated and washed three times. The cells 




Table 1. Effect of ESBI  and II on solid tumor growth.  
 
Group Dose (mg/kg) Tumor weight (g) Inhibition rate (%) 
Control Vehicle 2.89±0.17 — 
CTX 25 1.07±0.08* 62.98% 
    
ESBI  1000 1.16±0.11* 59.86% 
500 1.54±0.14* 46.71% 
250 1.65±0.08* 42.91% 
    
ESBII 
1000 1.46±0.12* 49.48% 
500 1.64±0.13* 43.25% 
250 1.81±0.16* 37.37% 
 





were overnight fixed with cold 70% ethanol, and then stained with 
propidium Iodide (PI) solution consisting of RNase for 30 min in 
dark. The percentage of cells in each phase of the cell cycle and 
apoptosis were detected in an EPICS XL flow cytometry equipped 
with a 488 nm argon laser using ModFIT. 
 
 
Effect of ESBI and II on TNF-α in serum 
 
The blood samples of all animals were collected via eyeball before 
the mice were killed. The blood samples were kept at room 
temperature for 20 min, and then centrifugated at the speed of 2000 
rpm for 20 min, finally the supernatant was collected. The content of 
serum TNF-α was determined by following the procedure of Mouse 
TNF-α ELISA Kit. 
 
 
Effect of ESBI and II on expression of Bcl-2 and Bax protein in 
tumor tissues 
 
The harvested tumors of all groups were fixed in 10% formalin, 
embedded in paraffin and cut into 4 μm sections. The tumor tissue 
sections were stained with standard immunohistochemical 
streptavidin/peroxidase (SP) method and observed with light 
microscope. The cells with distinct brown color in cytoplasmic or 
membrane were considered to be positive cells. The number of 
positive cells and negative cells in five random selected eyesight of 
each section was counted. The rates of Bcl-2 and Bax positive cells 
were calculated by the following formula: The rate of positive cells 
(%) = the number of positive cells/(the number of positive cells + the 
number of negative cells) × 100%. 
 
 
Statistical analysis  
 
The statistical software SPSS13.0 was applied in the data 
processing. The data were shown as mean ± standard deviation 
(SD). Statistical comparison among treatments was carried out 
using one-way analysis of variance (ANOVA). The statistical 
significances between control and drug treatment groups were 






Effect of ESBI and II on solid tumor growth 
 
On day 15,  the  mice were  killed  and  the  tumors  of  all  
groups were harvested, and then the tumor inhibition 
rates were calculated. As we can see from Table 1, the 
tumor weights of the CTX group, and the ESBI and II 
groups were decreased significantly (P<0.05) compared 
with the control group. The tumor weights of the ESBI 
groups (1000, 500 and 250 mg/kg) were less than those 
of the ESBII groups. The results show that both of the 
tumor inhibition rates in the ESBI groups and the ESBII 
groups were less than that of CTX group, but bigger than 
30%. There was a reduction in the tumor inhibition rate of 
the ESBII groups compared with the ESBI groups. 
However, the tumor inhibition rates of the ESBI groups 
and the ESBII groups became to reduce with the dose 
reducing from 1000 to 250 mg/kg. 
 
 
Effect of ESBI  and ESBII on tumor cell morphology 
 
The apoptotic cells in tumor tissues of drug treated 
groups were increased significantly compared with the 
control group, and the tumor cells were getting shrinkage 
and separated with the surrounding cells. Besides, the 
nuclear chromatin of the ESBI and II groups were 
agglomerated and showed the characteristics of 
apoptosis. The number of apoptotic cells in the CTX 
group was more than those of the rest groups, and the 
number of apoptotic cells in the high dose ESBI group 
was just less than that of the CTX group but more than 
those of the rest groups (Figure 1).  
 
 
Effect of ESBI and II on cell cycle and cells apoptosis 
of tumor tissues 
 
The cell cycle and apoptosis of U14 tumor tissues were 
detected by flow cytometry. Compared with the control 
group, the tumor cells of the CTX, ESBI  and II                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
groups got reduced at G0/G1 phase significantly (P<0.05), 
while increased at S phase (P<0.05), and the tumor cells 
remained almost unchanged at G2/M phase. The results 
prompted   that  the  cell  cycles  could  be  arrested  at  S  






Figure 1. Tumor tissue section of H.E.staining (10×40); A, tumor tissue section of control group; 
B, tumor tissue section of CTX group; C, tumor tissue section of high dose ESBI group; D, tumor 
tissue section of middle dose ESBI group; E, tumor tissue section of low dose ESBI group; F, 
tumor tissue section of high dose ESBII group; G, tumor tissue section of middle dose ESBII 




phase by ESBI and II groups. What is more, the 
percentage of apoptosis cells could be significantly 
increased (P<0.05) by the ESBI  and II groups in contrast 
to the control group. The percentage of apoptosis cells in 
the ESBII groups was less than that of the ESBI groups. 
All of the results indicated that ESBI  and II could induce 
the apoptosis of tumor, but the effects of inducing 
apoptosis in the ESBI  groups were stronger than those 
of the ESBII groups (Table 2). 
 
 
Effect of ESBI and II on TNF-α in serum 
 
The content of TNF-α in serum was detected by ELISA 
kit. The content of TNF-α in the CTX group and ethanol 
extract of S. baicalensis groups got a significant addition 
compared with the control group (P<0.05). In addition, the 
content of TNF-α in the ESBI groups were bigger than 
those of the ESBII groups between the  same  does.  The 
results suggested that the content of TNF-α in serum 
could be increased by the ethanol extract of S. 
baicalensis, and the effects of increasing the content of 
TNF-α in the ESBI groups were better than those of the 
ESBII groups (Figure 2). 
 
 
Effect of ESBI and II on expression of Bcl-2 and Bax 
protein in tumor tissues 
 
In order to further study the mechanism of the ethanol 
extract of S. baicalensis on U14 cervical cancer mice, the 
expression of Bcl-2 and Bax protein in tumor tissues was 
detected by immunohistochemical and shown in Figures 
3 and 4, the statistical results of Bcl-2 and Bax expres-
sion were shown in Table 3. There was a significant 
reduction on Bcl-2 positive cells in the tumor tissues of 
the CTX group and ethanol extract of S. baicalensis 
groups  compared  with  the  control  group (P<0.05). The  




Table 2. Effect of ESBI  and II on cell cycle and apoptosis of tumor cells.  
 
Group Treatment (mg/kg) G0/G1 (%) S (%) G2/M (%) Percentage of apoptosis cell (%) 
Control Vehicle 63.96±3.34 28.49±2.01 7.54±1.21 10.86±0.37 
CTX 
25 57.82±2.62* 32.43±1.85* 9.75±0.87
#
 27.52±0.32* 
     
ESBI  
1000 50.20±2.01* 42.01±1.47* 7.79±1.01
#
 21.68±0.91* 
500 52.61±1.77* 39.90±1.62* 7.49±0.52
#
 17.50±1.02* 
250 54.73±1.89* 37.89±2.09* 7.38±0.18
#
 13.31±0.83* 
     
ESBII 
1000 51.20±1.76* 40.40±3.01* 8.40±0.54
#
 15.73±1.41* 
500 57.18±2.10* 33.80±2.42* 9.02±0.65
#
 13.96±1.22* 












Figure 2. Effect of ESBI  and II on TNF-α in serum; ESBI H, ESBI M and ESBI L: represent, 
respectively for the dose of 1000, 500 and 250 mg/kg of ESBI . ESBIIH, ESBIIM and ESBIIL: represent, 




Bax positive cells were increased significantly in the CTX 
group and the ESBI groups compared with the control 
group (P<0.05). However, there was no significant 
difference between the ESB II groups and control group 
(P>0.05). All of the ratioes of Bax/Bcl-2 in the ethanol 
extract of S. baicalensis groups were bigger than that of 





Apoptosis is a kind of programmed cell death, and many 
kinds of mechanism such as gene  regulation  and  signal 
transduction were involved. Inducing cell apoptosis is an 
effective way of cancer treatment, and many kinds of 
plant amedica can induce the apoptosis of cancer cells. 
The mechanisms of plant amedica inducing apoptosis 
include that arresting the cell cycle and inhibiting the 
proliferation of cancer cells (Wang et al., 2011), regulating 
the expression of anti-apoptotic protein and pro-apoptotic 
protein (Wang et al., 2006; Hiroki et al., 2011), affecting 
the signal pathway of cell apoptosis (Li et al., 2008), 
regulating the expression and activity of telo-merase 
(Cheng et al., 2003), improving the body immune (Li et 
al., 2008) and so on. However, the composition in plant   
amedica      is    very      complex,      and      the      active  






Figure 3. Effect of ESBI  and II on expression of Bcl-2 protein in tumor tissues; A, tumor tissue section of control 
group; B, tumor tissue section of CTX group; C, tumor t issue section of high dose ESBI group; D, tumor tissue 
section of middle dose ESBI group; E, tumor tissue section of low dose ESBI group; F, tumor tissue section of 





ingredients and concentration may be different due to the 
difference of extraction method and condition, so the 
effect and mechanism of plant amedica extract on cancer 
cells may be different. In order to discover the effect of 
different herb extraction on pharmacological effect, we 
further separated the ethanol extract of S. baicalensis 
George and the 30% ethanol and 50% ethanol were used 
as the eluent of silica gel column chromatography and 
ESBI and II were gotten respectively from the ethanol 
extract of S. baicalensis.  
The definite component  of  ESBI  and  II  might  not  be 
same because  of  the  different  concentration  of  eluent.  
The mice with U14 tumor were treated respectively with 
ESBI and II, and the results showed that ESBI and II 
could inhibit the growth of U14 tumor with the highest 
inhibition rate of 59.86%. After detecting by H.E. dyeing 
and flow cytometry, both ESBI and II could induce the 
apoptosis of tumor, but the induction extent was different 
between the two kinds of ingredient, and the inhibition 
rates in the ESBI groups were bigger than those of the 
same dose of the ESBII groups. The abnormality of cell 
cycle regulation is one of the  important  reasons  in  
tumor  development, and cell apoptosis could be induced 
by arresting  the  cell  cycle.  According  to  our  research,






Figure 4. Effect of ESBI  and II on expression of Bax protein in tumor tissues; A, tumor tissue section of 
control group; B, tumor tissue section of CTX group; C, tumor tissue section of high dose ESBI group; D, 
tumor tissue section of middle dose ESBI group; E, tumor tissue section of low dose ESBI group; F, tumor 
tissue section of high dose ESBII group; G, tumor tissue section of middle dose ESBII group; H, tumor 




Table 3. Effect of ESBI  and II on expression of Bcl-2 and Bax protein.  
 
Group Treatment (mg/kg) Bcl-2 positive cells (%) Bax positive cell (%) Bax/Bcl-2 
Control Vehicle 53.28±4.46 13.33±0.62 0.25 
CTX 25 35.42±2.82* 35.12±2.93* 0.99 
     
ESBI  
1000 37.51±1.27* 30.27±1.52* 0.81 
500 39.80±2.21* 28.66±2.41* 0.72 
250 46.38±1.19* 24.73±2.03* 0.53 
     
ESBII 
1000 40.62±1.04* 16.90±2.36 0.41 
500 47.84±2.06* 14.06±1.20 0.29 
250 48.26±2.42* 15.63±1.78 0.32 
 





the tumor cell cycle could be arrested at S phase by ESBI 
and II. So we supposed that the ethanol extract of S. 
baicalensis Georgi could induce the apoptosis of tumor 
cells by arresting the cell cycle.  
TNF-α is an important immune response-modifying 
cytokines produced primarily by the cells of monocytic 
lineage and can enhance the immune function, 
meanwhile it also can enhance the anti-tumor response 
and promote tumor regression (EI-Obeid et al., 2006). 
The content of TNF-α in serum of the ESBI and II groups 
was bigger than that of the control group in our 
experiment; the consequence indicated that the immune 
function of mice could be enhanced by ESBI  and II.  
So far the mechanisms of apoptosis are becoming 
clear and the key protein and apoptosis-related genes in 
the apoptosis pathway have become a molecular target 
of anti-cancer drug. In cancer therapy, increasing the 
activity of pro-apoptotic genes selectively and/or inhibiting 
the expression of anti-apoptotic genes can not only 
enhance the efficacy of chemotherapy of radiotherapy, 
but also reduce the toxic side-effects of drug (Zhou and 
Huang, 2004). Therefore, inducing the apoptosis of tumor 
and reducing the apoptosis of healthy tissue cells have 
become a hot topic in cancer treatment. Pro-apoptotic 
gene Bax and anti-apoptotic gene Bcl-2 play an important 
role in regulating the apoptosis of tumor as the most 
representative members of Bcl-2 family. The expression 
of Bcl-2 and Bax in tumor cells was examined by 
immunohistochemistry in our research. The results 
showed that the Bcl-2 positive cells in tumor tissues of 
the ESBI  and II groups were decreased significantly and 
the Bax positive cells in tumor tissues of the ESBI  
groups showed a significant increase, meanwhile the 
ratios of Bax/Bcl-2 in the ESBI  and II groups were bigger 
than that of the control group. Our study indicated that 
the two ingredients ethanol extract from S. baicalensis 
could induce the apoptosis of tumor by down regulating 
the level of Bcl-2 gene and up regulating the level of Bax 
gene in tumor tissues. 
In summary, ESBI and II which were extracted from S. 
baicalensis could inhibit the growth of U14 cervical 
cancer cells of mice and induce the cells apoptosis by 
arresting cell cycle at S phase and regulating the 
expression of Bcl-2 and Bax gene. Besides, the content 
of TNF-α in serum could be increased by ESBI and II, 
thus the immune function of mice was also strengthened. 
However, the chemical composition and the concen-
tration of ingredients in ESBI  and II may be different due 
to the difference of extraction method, so the effect of 
ESBI  and II on cervical cancer was significantly different, 
the effect of ESBI  on inducing cells apoptosis and 
enhancing the immune function was better than that of 
ESBII. The anti-cancer mechanism of the ethanol extract 
from S. baicalensis and the difference reasons of the anti-
tumor effects of ESBI and II remain to be further studied. 
 
 






ESBI, ethanol extract I of Scutellaria baicalensis Georgi; 
ESBII, ethanol extract II of Scutellaria baicalensis Georgi; 
CTX, cyclophosphamide; H.E, hematoxylin and eosin; 
TNF-α, tumor necrosis factor alpha; ELISA, enzyme-
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